Announcement on Conclusion of a Global Strategic Cooperation and License Option Agreement with AbbVie Regarding the Development and Commercialization Rights of ZG006

About this update from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

Announcement on Conclusion of a Global Strategic Cooperation and License Option Agreement with AbbVie Regarding the Development and Commercialization Rights of ZG006 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A